Avatar - FOX Business
FOX Businessadded this to Markets
Avatar - FOX Business
Avatar - FOX Business

Better Buy: Intercept Pharmaceuticals vs. Madrigal Pharmaceuticals

FOX Business - Fox Business

Around 20 million Americans have a progressive, life-threatening liver condition called non-alcoholic steatohepatitis (NASH), and there's isn't much doctors can do about it besides recommending fewer calories and more exercise. Any day now, Intercept Pharmaceuticals (NASDAQ: ICPT) will share …

View on foxbusiness.com